ライフサイエンスコーパス: A-antigen

1 an ABH-glycan microarray, we quantified ABO-A antigen-subtype (A-subtype)-specific IgM and IgG in 53

2 firmed that alpha1,2-fucose-containing H and A antigens of the HBGA family were recognized by CNV.

3 ntigens (HBGAs) including fucose, Lewis, and A antigens.

4 s produced a vigorous memory response to B10.A antigens, suggesting immune activation was not inhibit

5 Human CENP-A antigen was overexpressed in insect cells using the ba

6 Consequently, A antigen expression on VWF was significantly elevated i

7 ucing terminus of the blood type-determining A-antigen and as the initial point of attachment to the

8 A-Tg mice expressed A-antigen on vascular endothelium and other cells includ

9 A-transgenic (A-Tg) mice were assessed for A-antigen expression by histology and flow cytometry.

10 develop alloantibodies to human glycophorin A antigen, we found reduced in vitro and in vivo Treg-su

11 that tolerance did not develop despite graft A antigen persistence.

12 (HMP) strategies, we demonstrate blood group A antigen loss of approximately 80% in as little as 2 h

13 y, we identified oligosaccharide blood group A antigen tetraose 6 (BGA6) as a biologically relevant G

14 In analogy with histo-blood group A antigen, Forssman (Fs) antigen terminates with alpha3-

15 st alpha-gustducin and the human blood group A antigen.

16 odon 12 and all tumors expressed blood group A antigen.

17 by possession of the Lancefield group A antigen.

18 plautii to enzymatically convert blood group A antigens from the renal vasculature of human kidneys t

19 its versatility for synthesis of blood group A antigens.

20 uman alloreactive CD8(+) T cells against HLA A antigens were MHC restricted and demonstrated a public

21 Although HLA-A antigens were detected by CMC in all cell lines tested

22 including transfusion, small variability in A antigen levels, and rare ABO*A2.06 and ABO*A2.16 seque

23 validated with both SARS-CoV-2 and influenza A antigens from clinical nasopharyngeal swab samples (PC

24 ome coronavirus 2 (SARS-CoV-2) and influenza A antigens in nasopharyngeal swab samples at diagnostica

25 (+) or CD8(+) T cells to conserved influenza A antigens in peripheral blood did not affect nasopharyn

26 ll responses to conserved internal influenza A antigens.

27 eg, A(2)) subtype donors, which express less A antigen, can be safely transplanted into group B recip

28 The Sialyl Lewis A antigen, or CA 19-9, is the prototype serum biomarker

29 ells preferentially display the sialyl Lewis A antigen.

30 s) raised against the L1 proteins of lineage A antigens.

31 Mice immunized with engineered lipid A/antigen emulsions exhibited robust IgG titers, indicat

32 e immunodominant T cell-defined MART-1/Melan-A antigen and downregulation of the TAP-1 gene in a recu

33 ens (CTAs) including anti-apoptotic melanoma-A antigens (MAGEAs).

34 th, particularly in individuals with mucosal A-antigen.

35 residues in NV P-particle binding to native A antigen.

36 Their erythrocytes had no A antigens but instead expressed Fs glycolipids.

37 chemical studies demonstrated high levels of A antigen on various glycoproteins (GPs) from high-expre

38 elets contained higher than normal levels of A antigen were subdivided into 2 groups, designated Type

39 nly the A type 3 antigen among four types of A antigens tested.

40 Overall, A antigen on platelet membranes, glycoproteins, and glyc

41 A panel of 17 Salmonella Typhi and Paratyphi A antigens was purified and used to determine antigen-sp

42 Histo-blood group A transferase produces A antigens and transfers GalNAc to the acceptor substrat

43 and VA387 (GII-4), which recognize the same A antigen but differ in that NV is unable to bind to the

44 tibodies specific for A-II glycans, the sole A-antigen subtype in vascular endothelium, from other an

45 D-galactosaminyltransferase that synthesizes A antigens.

46 The A antigen appeared on taste-bud cells that also expresse

47 In addition, the A antigen was present on many cells that lacked alpha-gu

48 r of cells expressing alpha-gustducin or the A antigen in regenerated taste buds; in the CTX animals

49 he porcine and bovine mucins, suggesting the A antigen as a possible factor for cross-species transmi

50 The P[III] VP8* proteins also bind the A antigens of the porcine and bovine mucins, suggesting

51 ral studies indicate that 5-FdU binds in the A'-antigen-binding pocket of MR1, positioning the deoxyr

52 bserved a new pattern of binding to the type A antigen which is distinct from that of the P[II] RVs.

53 antibodies that react with human blood type A antigens in neurons.

54 ase 109 (GH109) that is active on blood type A-antigen, along with a new subfamily of glycoside hydro

55 ally encode a protein with weak and variable A antigen synthetic ability.

56 erotype 8 vector that expresses an anti-VEGF-A antigen-binding fragment, which provides potential for